Sams, C.; Jones, K.; Galea, K.S.; MacCalman, L.; Cocker, J.; Teedon, P.; Cherrie, J.W.; Van Tongeren, M.
Development of a Biomarker for Penconazole: A Human Oral Dosing Study and a Survey of UK Residents’ Exposure. Toxics 2016, 4, 10.
https://doi.org/10.3390/toxics4020010
AMA Style
Sams C, Jones K, Galea KS, MacCalman L, Cocker J, Teedon P, Cherrie JW, Van Tongeren M.
Development of a Biomarker for Penconazole: A Human Oral Dosing Study and a Survey of UK Residents’ Exposure. Toxics. 2016; 4(2):10.
https://doi.org/10.3390/toxics4020010
Chicago/Turabian Style
Sams, Craig, Kate Jones, Karen S. Galea, Laura MacCalman, John Cocker, Paul Teedon, John W. Cherrie, and Martie Van Tongeren.
2016. "Development of a Biomarker for Penconazole: A Human Oral Dosing Study and a Survey of UK Residents’ Exposure" Toxics 4, no. 2: 10.
https://doi.org/10.3390/toxics4020010
APA Style
Sams, C., Jones, K., Galea, K. S., MacCalman, L., Cocker, J., Teedon, P., Cherrie, J. W., & Van Tongeren, M.
(2016). Development of a Biomarker for Penconazole: A Human Oral Dosing Study and a Survey of UK Residents’ Exposure. Toxics, 4(2), 10.
https://doi.org/10.3390/toxics4020010